FDA Inspection 1046035 — The Mount Sinai Hospital

The Mount Sinai Hospital — FEI 2470025

The FDA completed an inspection of The Mount Sinai Hospital on January 24, 2018 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 24, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)